Genefluence secures £1.3m for DNA-based lifestyle guidance

Genefluence Limited has reached an estimated post-money valuation of £40.9m following its most recent investment. The London-based company provides a genetic testing service that analyses subscriber DNA to deliver personalized recommendations for food, drink, and skincare products. These insights are delivered to users through a dedicated mobile application and the DnaBean wearable scanner.

The service targets consumers seeking lifestyle guidance based on their specific genetic profiles. Since its incorporation in 2024, the business has expanded its funding base, recording £957.6k in total investment during 2025. This latest round is estimated at £1.3m, while the aggregate funding for the 2026 calendar year stands at £1.2m.

Financial records for the year ended 31 January 2025 show the business operated with a team of four employees. Documentation for the most recent share allotment was filed in March (following a transaction completed in February).